Capstone Investment Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,644	Closed	-$40.2K	–	893
2025 Q1	$40.2K	Buy	+12,644	New	+$40.2K	﹤0.01%	518
2021 Q1	–	Sell	-17,776	Closed	-$63K	–	657
2020 Q4	$63K	Buy	+17,776	New	+$63K	﹤0.01%	512